Shuttle Pharmaceuticals names Bush & Associates as new auditor

SHPH•2026-11-06

Shuttle Pharmaceuticals engaged Bush & Associates as its independent auditor on November 2, 2026, replacing Forvis Mazars after the company files its quarterly report for the period ended September 30, 2026.

1. Auditor change

Shuttle Pharmaceuticals engaged Bush & Associates as its independent auditor on November 2, 2026, replacing Forvis Mazars after the filing of the quarterly report for the period ended September 30, 2026. Bush & Associates will audit the year ending December 31, 2026, and review interim financial statements for the first three quarters of 2027.

Sources

Shuttle Pharmaceuticals names Bush & Associates as new auditor

Sec

Shuttle Pharmaceuticals names Bush & Associates as new auditor

1. Auditor change

Related News

Bridgewater Bancshares director Todd B. Urness reports disposal of common shares worth $404,218

Agilysys grants CFO William David Wood III 5,143 restricted stock units

Ingredion publishes Q3 2026 earnings call transcript

Sources

Shuttle Pharmaceuticals names Bush & Associates as new auditor

Block director Anthony Mathew Eisen sells $3.06 million in common shares

WEC Energy forecasts 2026 EPS of $5.60-$5.64